Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Bariatric care has seen a lot of innovation in recent years, as the FDA has approved non-surgical solutions like the Spatz3, the first adjustable weight-loss balloon in the world
As the weight-loss market becomes increasingly crowded, differentiation will become harder
Truly, it's been a long stretch and many of us have struggled through it by quietly numbing ourselves with alcohol
Letter to the Editor: Can semaglutide result in a tangible cardiovascular benefit in [PMID: 38497771] Laboratory literature summary: Letter to the Editor: Can semaglutide result in a tangible cardiovascular benefit in recipients of liver transplants
US$ 27.74
US$ 22.50
US$ 27.59
US$ 25.76
